These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 7694075)
21. "Linkage region" sequences of heparins and heparan sulfates: detection and quantification by nuclear magnetic resonance spectroscopy. Iacomini M; Casu B; Guerrini M; Naggi A; Pirola A; Torri G Anal Biochem; 1999 Oct; 274(1):50-8. PubMed ID: 10527496 [TBL] [Abstract][Full Text] [Related]
22. Evidence that carboxyl-reduced heparin fails to potentiate acidic fibroblast growth factor activity due to an inability to interact with cell surface heparin receptors. Brown KJ; Hendry IA; Parish CR Exp Cell Res; 1995 Mar; 217(1):132-9. PubMed ID: 7532589 [TBL] [Abstract][Full Text] [Related]
23. One- and two-dimensional 1H-NMR characterization of two series of sulfated disaccharides prepared from chondroitin sulfate and heparan sulfate/heparin by bacterial eliminase digestion. Yamada S; Yoshida K; Sugiura M; Sugahara K J Biochem; 1992 Oct; 112(4):440-7. PubMed ID: 1337080 [TBL] [Abstract][Full Text] [Related]
24. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin. Brown KJ; Hendry IA; Parish CR J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903 [TBL] [Abstract][Full Text] [Related]
25. Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence. Okada Y; Yamada S; Toyoshima M; Dong J; Nakajima M; Sugahara K J Biol Chem; 2002 Nov; 277(45):42488-95. PubMed ID: 12213822 [TBL] [Abstract][Full Text] [Related]
26. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin. Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695 [TBL] [Abstract][Full Text] [Related]
27. Domain structure of heparan sulfates from bovine organs. Maccarana M; Sakura Y; Tawada A; Yoshida K; Lindahl U J Biol Chem; 1996 Jul; 271(30):17804-10. PubMed ID: 8663266 [TBL] [Abstract][Full Text] [Related]
28. Liver heparan sulfate structure. A novel molecular design. Lyon M; Deakin JA; Gallagher JT J Biol Chem; 1994 Apr; 269(15):11208-15. PubMed ID: 8157650 [TBL] [Abstract][Full Text] [Related]
29. Structural studies on the oligosaccharides isolated from bovine kidney heparan sulphate and characterization of bacterial heparitinases used as substrates. Sugahara K; Tohno-oka R; Yamada S; Khoo KH; Morris HR; Dell A Glycobiology; 1994 Aug; 4(4):535-44. PubMed ID: 7827415 [TBL] [Abstract][Full Text] [Related]
30. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Casu B; Naggi A; Torri G Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374 [TBL] [Abstract][Full Text] [Related]
31. Sugar Chips immobilized with synthetic sulfated disaccharides of heparin/heparan sulfate partial structure. Wakao M; Saito A; Ohishi K; Kishimoto Y; Nishimura T; Sobel M; Suda Y Bioorg Med Chem Lett; 2008 Apr; 18(7):2499-504. PubMed ID: 18343110 [TBL] [Abstract][Full Text] [Related]
32. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. Pye DA; Vivès RR; Hyde P; Gallagher JT Glycobiology; 2000 Nov; 10(11):1183-92. PubMed ID: 11087710 [TBL] [Abstract][Full Text] [Related]
33. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. Lyon M; Deakin JA; Mizuno K; Nakamura T; Gallagher JT J Biol Chem; 1994 Apr; 269(15):11216-23. PubMed ID: 8157651 [TBL] [Abstract][Full Text] [Related]
34. Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide. Ogura K; Nagata K; Hatanaka H; Habuchi H; Kimata K; Tate S; Ravera MW; Jaye M; Schlessinger J; Inagaki F J Biomol NMR; 1999 Jan; 13(1):11-24. PubMed ID: 10070748 [TBL] [Abstract][Full Text] [Related]
35. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin. Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825 [TBL] [Abstract][Full Text] [Related]
36. The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues. Schmidt A; Yoshida K; Buddecke E J Biol Chem; 1992 Sep; 267(27):19242-7. PubMed ID: 1527046 [TBL] [Abstract][Full Text] [Related]
37. Thymic epithelial cells synthesize a heparan sulfate with a highly sulfated region. Werneck CC; Oliveira-Dos-Santos AJ; Silva LC; Villa-Verde DM; Savino W; Mourão PA J Cell Physiol; 1999 Jan; 178(1):51-62. PubMed ID: 9886490 [TBL] [Abstract][Full Text] [Related]
38. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Fromm JR; Hileman RE; Weiler JM; Linhardt RJ Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372 [TBL] [Abstract][Full Text] [Related]
39. Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid. Bienkowski MJ; Conrad HE J Biol Chem; 1985 Jan; 260(1):356-65. PubMed ID: 3965453 [TBL] [Abstract][Full Text] [Related]
40. Conformation and dynamics of heparin and heparan sulfate. Mulloy B; Forster MJ Glycobiology; 2000 Nov; 10(11):1147-56. PubMed ID: 11087707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]